+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Drugs By Therapeutic Area Market Research Reports

HER2 Antibodies - Global Strategic Business Report - Product Thumbnail Image

HER2 Antibodies - Global Strategic Business Report

  • Report
  • May 2026
  • 137 Pages
  • Global
From
Short Bowel Syndrome (SBS) - Global Strategic Business Report - Product Thumbnail Image

Short Bowel Syndrome (SBS) - Global Strategic Business Report

  • Report
  • May 2026
  • 174 Pages
  • Global
From
Ulcerative Colitis Therapeutics - Global Strategic Business Report - Product Thumbnail Image

Ulcerative Colitis Therapeutics - Global Strategic Business Report

  • Report
  • May 2026
  • 208 Pages
  • Global
From
Pigmentation Disorders Treatment - Global Strategic Business Report - Product Thumbnail Image

Pigmentation Disorders Treatment - Global Strategic Business Report

  • Report
  • May 2026
  • 380 Pages
  • Global
From
Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs - Global Strategic Business Report - Product Thumbnail Image

Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs - Global Strategic Business Report

  • Report
  • May 2026
  • 218 Pages
  • Global
From
Lipid Disorder Treatment - Global Strategic Business Report - Product Thumbnail Image

Lipid Disorder Treatment - Global Strategic Business Report

  • Report
  • May 2026
  • 393 Pages
  • Global
From
Non-opioid Pain Patch - Global Strategic Business Report - Product Thumbnail Image

Non-opioid Pain Patch - Global Strategic Business Report

  • Report
  • May 2026
  • 483 Pages
  • Global
From
Non-Alcoholic Steatohepatitis (NASH) Treatment - Global Strategic Business Report - Product Thumbnail Image

Non-Alcoholic Steatohepatitis (NASH) Treatment - Global Strategic Business Report

  • Report
  • May 2026
  • 216 Pages
  • Global
From
Thrombin - Global Strategic Business Report - Product Thumbnail Image

Thrombin - Global Strategic Business Report

  • Report
  • May 2026
  • 225 Pages
  • Global
From
Thalassemia Treatment - Global Strategic Business Report - Product Thumbnail Image

Thalassemia Treatment - Global Strategic Business Report

  • Report
  • May 2026
  • 196 Pages
  • Global
From
Subcutaneous Immunoglobulin - Global Strategic Business Report - Product Thumbnail Image

Subcutaneous Immunoglobulin - Global Strategic Business Report

  • Report
  • May 2026
  • 226 Pages
  • Global
From
Stretch Marks Treatment - Global Strategic Business Report - Product Thumbnail Image

Stretch Marks Treatment - Global Strategic Business Report

  • Report
  • May 2026
  • 280 Pages
  • Global
From
Plasma Protease C1-inhibitor Treatment - Global Strategic Business Report - Product Thumbnail Image

Plasma Protease C1-inhibitor Treatment - Global Strategic Business Report

  • Report
  • May 2026
  • 271 Pages
  • Global
From
Antiemetic Drugs - Global Strategic Business Report - Product Thumbnail Image

Antiemetic Drugs - Global Strategic Business Report

  • Report
  • May 2026
  • 204 Pages
  • Global
From
Epinephrine Autoinjectors - Global Strategic Business Report - Product Thumbnail Image

Epinephrine Autoinjectors - Global Strategic Business Report

  • Report
  • May 2026
  • 230 Pages
  • Global
From
Abortion Drugs - Global Strategic Business Report - Product Thumbnail Image

Abortion Drugs - Global Strategic Business Report

  • Report
  • May 2026
  • 280 Pages
  • Global
From
Alexipharmic Drugs - Global Strategic Business Report - Product Thumbnail Image

Alexipharmic Drugs - Global Strategic Business Report

  • Report
  • May 2026
  • 290 Pages
  • Global
From
Drug Delivery Across Blood Brain Barriers - Global Strategic Business Report - Product Thumbnail Image

Drug Delivery Across Blood Brain Barriers - Global Strategic Business Report

  • Report
  • May 2026
  • 297 Pages
  • Global
From
Erdosteine - Global Strategic Business Report - Product Thumbnail Image

Erdosteine - Global Strategic Business Report

  • Report
  • May 2026
  • 274 Pages
  • Global
From
Male Urinary Incontinence - Global Strategic Business Report - Product Thumbnail Image

Male Urinary Incontinence - Global Strategic Business Report

  • Report
  • May 2026
  • 563 Pages
  • Global
From
Loading Indicator

The Drugs by Therapeutic Area market is a segment of the pharmaceutical industry that focuses on the development and sale of drugs for specific medical conditions. These drugs are designed to treat a wide range of diseases, from cancer to mental health disorders. Companies in this market typically specialize in one or more therapeutic areas, such as oncology, neurology, or cardiology. They develop drugs that target specific medical conditions and then market them to healthcare providers and patients. Companies in this market include Pfizer, Merck, Novartis, GlaxoSmithKline, and Sanofi. Show Less Read more